CST9L

cystatin 9 like, the group of Cystatins, type 2

Basic information

Region (hg38): 20:23564732-23568484

Links

ENSG00000101435NCBI:128821OMIM:616536HGNC:16233Uniprot:Q9H4G1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CST9L gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CST9L gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
10
clinvar
10
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 10 0 0

Variants in CST9L

This is a list of pathogenic ClinVar variants found in the CST9L region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-23568224-G-T not specified Uncertain significance (Nov 15, 2021)2261325
20-23568232-G-C not specified Uncertain significance (Oct 21, 2024)3497988
20-23568281-G-A not specified Uncertain significance (Jul 19, 2023)2594846
20-23568293-A-G not specified Uncertain significance (Oct 04, 2022)2316421
20-23568308-G-A not specified Uncertain significance (Nov 20, 2024)3497987
20-23568309-G-A not specified Uncertain significance (Jan 04, 2024)3078431
20-23568315-A-T not specified Uncertain significance (Oct 10, 2023)3078430
20-23568324-T-C not specified Uncertain significance (Feb 28, 2023)2490660
20-23568341-C-T not specified Uncertain significance (Jul 08, 2022)2309696
20-23568377-A-G not specified Uncertain significance (Oct 20, 2024)3497989

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CST9Lprotein_codingprotein_codingENST00000376979 34018
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.99e-120.0024212550432331257400.000939
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.4698674.61.150.00000364970
Missense in Polyphen2319.2171.1968289
Synonymous0.08053131.60.9820.00000161268
Loss of Function-2.71135.892.212.51e-768

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004120.000412
Ashkenazi Jewish0.002680.00268
East Asian0.000.00
Finnish0.00004620.0000462
European (Non-Finnish)0.0004930.000492
Middle Eastern0.000.00
South Asian0.004570.00448
Other0.0004890.000489

dbNSFP

Source: dbNSFP

Intolerance Scores

loftool
0.773
rvis_EVS
0.93
rvis_percentile_EVS
89.66

Haploinsufficiency Scores

pHI
0.0926
hipred
N
hipred_score
0.112
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0314

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Gene ontology

Biological process
negative regulation of endopeptidase activity
Cellular component
extracellular region
Molecular function
cysteine-type endopeptidase inhibitor activity;protein binding